Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Journal: The Biochemical journal 20130415
Title: Neuregulin directly decreases voltage-gated sodium current in hippocampal ErbB4-expressing interneurons.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20121003
Title: Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.
Journal: ChemMedChem 20120401
Title: Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons.
Journal: Nature neuroscience 20111211
Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111101
Title: Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.
Journal: Journal of medicinal chemistry 20100923
Title: Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential.
Journal: Toxicology and applied pharmacology 20070515
Title: Pharmacology of epidermal growth factor inhibitors.
Journal: The International journal of biological markers 20070101
Title: Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue.
Journal: Neoplasia (New York, N.Y.) 20060701
Title: Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3'-kinase and mitogen-activated protein kinase.
Journal: Journal of neuroscience research 20050815
Title: Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20050518
Title: Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes.
Journal: Molecular pharmacology 20050401
Title: G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein.
Journal: Experimental cell research 20050201
Title: Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA.
Journal: Journal of medicinal chemistry 20041007
Title: Extracellular oxidation by taurine chloramine activates ERK via the epidermal growth factor receptor.
Journal: The Journal of biological chemistry 20040730
Title: Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
Journal: Glia 20030801
Title: Dissociation of focal adhesion kinase and paxillin tyrosine phosphorylation induced by bombesin and lysophosphatidic acid from epidermal growth factor receptor transactivation in Swiss 3T3 cells.
Journal: Journal of cellular physiology 20030301
Title: Neuregulin-1beta modulates in vivo entorhinal-hippocampal synaptic transmission in adult rats.
Journal: Neuroscience 20030101
Title: Metalloproteinases stimulate ErbB-dependent ERK signaling in human skin organ culture.
Journal: The Journal of biological chemistry 20020726
Title: Effect of tyrosine kinase inhibitors on clathrin-coated pit recruitment and internalization of epidermal growth factor receptor.
Journal: The Journal of biological chemistry 20020726
Title: Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis.
Journal: Biochemical and biophysical research communications 20020712
Title: N-acetylcysteine inhibits angiotensin ii-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor.
Journal: Biochemical and biophysical research communications 20010202
Title: Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor.
Journal: Journal of medicinal chemistry 19970606
Title: Fry DW, et al. Biochemical and antiproliferative properties of 4-[ar(alk)ylaminopyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor. Biochem Pharmacol. 1997 Oct 15;54(8):877-87.
